¼¼°èÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå(2025³â)
Downstream Processing Global Market Report 2025
»óǰÄÚµå : 1667683
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,339,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,163,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,987,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ ±Þ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. CAGR 13.5%·Î ÃßÀÌÇϸç, 2029³â¿¡´Â 589¾ï 6,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¹ÙÀÌ¿ÀÀǾàǰ ¼ö¿ä Áõ°¡, Áö¼Ó°¡´ÉÇÑ Ä£È¯°æ °øÁ¤¿¡ ´ëÇÑ °ü½É, °øµ¿ ¿¬±¸ ¹× ÆÄÆ®³Ê½Ê, Áö¼ÓÀûÀÎ ¹ÙÀÌ¿ÀÇÁ·Î¼¼½º µµÀÔ, ¸ÂÃãÇü ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µî¿¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â µðÁöÅÐÈ­¿Í Àδõ½ºÆ®¸® 4.0ÀÇ ÅëÇÕ, ±â¼ú ¹ßÀü, ÀÏȸ¿ë ½Ã½ºÅÛ, ¹ÙÀÌ¿ÀÀǾàǰ »ê¾÷ÀÇ ¼ºÀå, ¿¬¼Ó ó¸® µîÀÌ ÀÖ½À´Ï´Ù.

¿¹»óµÇ´Â ÀÇ·áºñ Áõ°¡´Â ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀå µ¿·ÂÀÌ µÉ °ÍÀÔ´Ï´Ù. ÀÇ·áºñ¿¡´Â ÀÇ·á ¼­ºñ½º, °¡Á· °èȹ Ȱµ¿, ¿µ¾ç ±¸»ó, °Ç°­ °ü·Ã ¸ñÀûÀ» À§ÇØ Æ¯º°È÷ ÇÒ´çµÈ ±ä±Þ Áö¿ø°ú °ü·ÃµÈ ¸ðµç ÁöÃâÀÌ Æ÷ÇԵ˴ϴÙ. ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½ÌÀº ¹ÚÅ׸®¾Æ³ª µ¿¹° ¼¼Æ÷¿Í °°Àº õ¿¬¹°·ÎºÎÅÍ ¿ø·áÀǾàǰ(DS)À» ÃßÃâÇϰí Á¤Á¦ÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÑ ÄÄÆ÷³ÍÆ®À̸ç, ÀÇ·áºñ Áõ°¡´Â ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½ÌÀÇ ¸ÅÃâÀ» °­È­ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ÀÇ Centers for Medicare & Medicaid Services¿¡ ÀÇÇÑ2021-2030³â ±¹¹Î ÀÇ·áºñ(NHE)¿¡ °üÇÑ º¸°í¼­¿¡ µû¸£¸é 2022³â 3¿ù ÇöÀç, ±¹¹Î ÀÇ·áºñÀÇ ¿¬°£ Áõ°¡À²Àº 2021-2030³â¿¡ Æò±Õ 5.1%, 2030³â¿¡´Â ¾à 6Á¶ 8,000¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °°Àº ±â°£ Áß Medicare ÁöÃâÀº ¿¬°£ 7.2%, Medicaid ÁöÃâÀº ¿¬°£ 5.6%·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ÀÇ·áºñ Áõ°¡´Â ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀåÀÇ ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿À Á¦¾à ºÎ¹®ÀÇ ¼ºÀå Àü¸Á¿¡ µû¶ó ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀåÀÇ ¼ºÀå¼¼°¡ Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ ºÎ¹®Àº »ý¹°ÇÐÀû ¿ø·á¿¡¼­ À¯·¡ÇÑ ÀǾàǰ ¹× Ä¡·á¹ýÀÇ °³¹ß, Á¦Á¶, »ó¾÷È­¸¦ Àü¹®À¸·Î ÇÏ´Â Á¦¾à »ê¾÷ÀÇ ÇÑ ºÎ¹®À¸·Î, ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½ÌÀº ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶ °øÁ¤¿¡¼­ Áß¿äÇÑ ´Ü°èÀ̸ç, ¾÷½ºÆ®¸² ÇÁ·Î¼¼½Ì ÈÄ ¾òÀº º¹ÀâÇÑ È¥ÇÕ¹°¿¡¼­ ¿øÇÏ´Â ¿ø·á¸¦ ºÐ¸®, Á¤Á¦, ³óÃàÇÏ´Â ¿ªÇÒÀ» ÇÕ´Ï´Ù. 2023³â 6¿ù, À¯·´ÀÇ ¾÷°è´ÜüÀÎ EFPIA´Â 2022³â À¯·´ÀÇ ÀǾàǰ ÃÑ»ý»ê¾×ÀÌ 3,842¾ï ´Þ·¯(3,400¾ï À¯·Î)¿¡ ´ÞÇϸç, 2021³â 3,662¾ï 6,700¸¸ ´Þ·¯(3,239¾ï 5,000¸¸ À¯·Î)·ÎºÎÅÍ ¾à 4.95% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ÙÀÌ¿ÀÀǾàǰ ºÐ¾ß ¼ö¿ä Áõ°¡´Â ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù.

¼¼°èÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¡¤Æ¯Â¡, ÁÖ¿ä µ¿Çâ, ½ÃÀå ¿µÇâ¿äÀÎÀÇ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ¡¤¿¹Ãø, °¢Á¾ ±¸ºÐ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : Ư¡

Á¦3Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : µ¿Ç⡤Àü·«

Á¦4Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : °Å½Ã°æÁ¦ ½Ã³ª¸®¿À(±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, COVID-19¿ÍÀÇ È¸º¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ Æ÷ÇÔ)

Á¦5Àå ¼¼°èÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : ¼ºÀå ºÐ¼®¡¤Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : ¼¼ºÐÈ­

Á¦7Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : Áö¿ª¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦9Àå Áß±¹ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦10Àå ÀεµÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦11Àå ÀϺ»ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦12Àå È£ÁÖÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦14Àå Çѱ¹ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦15Àå ¼­À¯·´ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦16Àå ¿µ±¹ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦17Àå µ¶ÀÏÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦18Àå ÇÁ¶û½ºÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾ÆÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦20Àå ½ºÆäÀÎÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦21Àå µ¿À¯·´ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦22Àå ·¯½Ã¾ÆÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦23Àå ºÏ¹ÌÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦25Àå ij³ª´ÙÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦26Àå ³²¹ÌÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦27Àå ºê¶óÁúÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦28Àå Áßµ¿ÀÇ ´Ù¿î½ºÆ®¸² °¡°ø ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä«ÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå

Á¦30Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : ±âŸ ´ëÇü ¹× Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : ÁÖ¿ä M&A

Á¦34Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : ÃÖ±Ù µ¿Çâ

Á¦35Àå ´Ù¿î½ºÆ®¸² ÇÁ·Î¼¼½Ì ½ÃÀå : ÀáÀ缺 ³ôÀº ±¹°¡¡¤ºÎ¹®¡¤Àü·«

Á¦36Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Downstream processing involves the retrieval and purification of a drug substance (DS) derived from natural sources such as animal or bacterial cells. It delineates the sequence of steps essential to generate a pure and uniform protein product from biological components such as cells, tissue culture fluid, or plant tissues.

Key products utilized in downstream processing encompass centrifuges, dryers, chromatography systems, filters, evaporators, and others. Various techniques are applied, including purification methods, solid-liquid separation, and clarification or concentration. Centrifuges are devices that leverage centrifugal force to separate materials based on different densities, eliminate moisture, or replicate the effects of gravity. They find applications in diverse areas such as monoclonal antibody production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and more.

The downstream processing market research report is one of a series of new reports from The Business Research Company that provides downstream processing market statistics, including downstream processing industry global market size, regional shares, competitors with a downstream processing market share, detailed downstream processing market segments, market trends and opportunities, and any further data you may need to thrive in the downstream processing industry. This downstream processing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The downstream processing market size has grown rapidly in recent years. It will grow from$31.26 billion in 2024 to $35.54 billion in 2025 at a compound annual growth rate (CAGR) of 13.7%. The growth in the historic period can be attributed to increasing biopharmaceutical investments, stringent regulatory standards, globalization of biopharmaceutical production, rising incidence of chronic diseases

The downstream processing market size is expected to see rapid growth in the next few years. It will grow to $58.96 billion in 2029 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to increasing demand for biopharmaceuticals, focus on sustainable and green processing, collaborations and partnerships, continuous bioprocessing adoption, increasing demand for personalized medicines. Major trends in the forecast period include digitalization and industry 40 integration, technological advancements, single-use systems, biopharmaceutical industry growth, continuous processing.

The anticipated increase in healthcare expenditure is poised to be a driving force for the future expansion of the downstream processing market. Healthcare expenditure encompasses all spending related to health services, family planning activities, nutrition initiatives, and emergency aid specifically allocated for health-related purposes. This heightened expenditure is expected to bolster the sales of downstream processing, a pivotal component in extracting drug substances (DS) from natural sources such as bacterial or animal cells and subsequently purifying the drug substance. According to the 2021-2030 National Health Expenditure (NHE) report by the Centers for Medicare & Medicaid Services in the United States, as of March 2022, the annual increase in national health spending is projected to average 5.1% between 2021 and 2030, reaching an approximate total of $6.8 trillion by 2030. Over the same period, Medicare expenditures are expected to grow at a 7.2% annual rate, while Medicaid spending is projected to increase at a 5.6% annual rate. Thus, the escalating healthcare expenditure significantly contributes to the downstream processing market's growth.

The anticipated growth in the biopharmaceutical sector is expected to drive the future expansion of the downstream processing market. The biopharmaceutical sector, a segment of the pharmaceutical industry specializing in the development, manufacturing, and commercialization of drugs and therapies derived from biological sources, is set to increase the demand for downstream processing (DSP). DSP is a crucial stage in the biopharmaceutical manufacturing process, responsible for isolating, purifying, and concentrating the desired drug substance from the complex mixture obtained after upstream processing. For instance, in June 2023, the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, reported that the total pharmaceutical production in Europe amounted to $384,200 million (€340,000 million) in 2022, reflecting an increase of approximately 4.95% from $366,267 million (€323,950 million) in 2021. Therefore, the rising demand in the biopharmaceutical sector is a key driver for the downstream processing market's growth.

A prominent trend gaining traction is the emphasis on product innovations. Leading companies in the market are dedicated to developing new technological solutions as part of their strategy to solidify their market presence. For example, in September 2022, Tosoh Bioscience LLC, a global chemical and specialty materials company based in the United States, introduced the Octave BIO Multi-Column Chromatography (MCC) system. This innovative system serves as a comprehensive solution for downstream process intensification, specifically designed for advanced biomolecule purification processes. Its modular design allows flexibility to accommodate diverse requirements, offering advantages such as resin and buffer cost savings.

A key focus of major companies in the downstream processing market is on pioneering solutions, including the implementation of flow cells to drive revenue growth. A flow cell is a specialized container designed for the continuous flow of liquid samples. For instance, in October 2023, SCHOTT AG, a Germany-based technology group specializing in specialty glass and glass-ceramics, launched ViewCell. This new component aims to facilitate safe and continuous process control, optimizing downstream operations in the biopharmaceutical industry. The flexibility provided by the viewcell flow cell is expected to enhance the efficiency of downstream processes in the biopharmaceutical industry.

In January 2023, Astea Bio separations, a UK-based provider of bioseparation and purification technologies, completed the acquisition of Delta Precision Ltd. for an undisclosed amount. This acquisition positions Astea Bio separations to strengthen its existing portfolio of bioprocessing resins, reusable columns, and prepacked single-use columns by incorporating a wide range of high-performance chromatography columns for biomanufacturing. Delta Precision Ltd., a UK-based manufacturer of advanced chromatography columns, produces products for various applications, including protein purification, vaccine production, and drug development.

Major companies operating in the downstream processing market include Sartorius AG, General Electric Company, Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Repligen Corporation, Lonza Group Ltd., Eppendorf AG, Corning Corporation, Ashai Kasei Corporation, Finesse Solutions Inc., MilliporeSigma, Pall Corporation, Bio-Rad Laboratories, Charles River Laboratories International Inc., Waters Corporation, Becton Dickinson and Company (BD), Entegris Inc., Novasep, Avantor Sciences, Tecan Group, Agilent Technologies, Boehringer Ingelheim International GmbH, Ahlstrom-Munksjo Oyj, Grifols S.A., GenScript Biotech Corporation

North America was the largest region in the downstream processing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global downstream processing market report during the forecast period. The regions covered in the downstream processing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the downstream processing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The downstream processing market consists of revenues earned by entities by providing downstream processing services such as cell separation, filtration, product recovery, extraction of products, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. The Downstream processing market also includes sales of small-scale fermenters, pilot-scale fermenters, centrifuges, and membrane filtration systems which are used in providing downstream processing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Downstream Processing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on downstream processing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for downstream processing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The downstream processing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Downstream Processing Market Characteristics

3. Downstream Processing Market Trends And Strategies

4. Downstream Processing Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Downstream Processing Growth Analysis And Strategic Analysis Framework

6. Downstream Processing Market Segmentation

7. Downstream Processing Market Regional And Country Analysis

8. Asia-Pacific Downstream Processing Market

9. China Downstream Processing Market

10. India Downstream Processing Market

11. Japan Downstream Processing Market

12. Australia Downstream Processing Market

13. Indonesia Downstream Processing Market

14. South Korea Downstream Processing Market

15. Western Europe Downstream Processing Market

16. UK Downstream Processing Market

17. Germany Downstream Processing Market

18. France Downstream Processing Market

19. Italy Downstream Processing Market

20. Spain Downstream Processing Market

21. Eastern Europe Downstream Processing Market

22. Russia Downstream Processing Market

23. North America Downstream Processing Market

24. USA Downstream Processing Market

25. Canada Downstream Processing Market

26. South America Downstream Processing Market

27. Brazil Downstream Processing Market

28. Middle East Downstream Processing Market

29. Africa Downstream Processing Market

30. Downstream Processing Market Competitive Landscape And Company Profiles

31. Downstream Processing Market Other Major And Innovative Companies

32. Global Downstream Processing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Downstream Processing Market

34. Recent Developments In The Downstream Processing Market

35. Downstream Processing Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â